---
schema_version: "secwatch.filing_event.v1"
accession: "0001779128-22-000081"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T02:13:25.642246+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Blade Q2 revenue up 175% to $35.6M; net income $8.4M vs loss year ago

## Summary
- Total revenue $35.6M, up 175% YoY; MediMobility revenue $17.2M (+1,013%) driven by Trinity acquisition.
- Short Distance revenue $11.0M (+89%) on Helijet acquisition and higher pricing; Flight Margin 14.3% vs 23.0% YoY.
- Net income $8.4M vs net loss $24.3M year ago; adjusted EBITDA loss $(6.1)M vs $(2.6)M.
- Europe acquisitions of three urban air mobility operators expected to close late Summer 2022.
- JetBlue partnership launched June 23; Blade Airport service run-rate above pre-pandemic levels.

## SEC filing metadata
- accession: 0001779128-22-000081
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000177912822000081/0001779128-22-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000177912822000081/blde-20220809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779128-22-000081
- JSON: https://secwatch.observer/filing/0001779128-22-000081.json
- Plain text: https://secwatch.observer/filing/0001779128-22-000081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.